Professor Christoph Brunner of Leuphana University in Germany will be hosted for one year at McGill University as the John G. Diefenbaker Awardee, where he will pursue a specialized research project, engage in teaching, lecturing and leading workshops, and exchange with other Canadian and US research communities. Prof. Brunner’s research revolves around the intersections between media, affect, and aesthetic politics.
Today, Iain Stewart, President of the National Research Council, Canada's largest federal research and development organization, announced the results of the inaugural round of the NRC’s New Beginnings Initiative. The New Beginnings Initiative is part of the NRC’s Ideation Fund, which was announced in Budget 2018 to encourage, test and validate transformative research ideas generated by NRC researchers working with external collaborators.
Today in Victoria, British Columbia, the Honourable Kirsty Duncan, Minister of Science and Sport, announced an investment of over $275 million for 346 new and renewed Canada Research Chairs at 52 institutions across Canada.
Assistance for McGill’s researchers and staff seeking to attract international meetings and conferences to Montréal
Business Events Montréal, a unit under the umbrella of the non-profit organization Tourism Montréal, has launched a program designed to help local universities attract international research conferences and meetings to Montréal.
Are you looking for research funding? The Office of Sponsored Research (OSR) is pleased to launch a new searchable database located on the Research and Innovation website. McGill’s academic and administrative staff members can access the database using their McGill email address and password.
Government of Canada invests in McGill and youth-led research project tackling sexual and gender-based violence
Today at La rue des femmes de Montréal, the Honourable Marc Garneau Minister of Transport, announced on behalf of the Honourable Maryam Monsef, Minister of International Development and Minister for Women and Gender Equality, an investment of more than $4.49 million for research tackling gender-based violence in Canada.
Martha Crago, Vice-Principal, Research and Innovation (VP-RI), is pleased to announce the appointment of Jean Saint-Vil to the role of Special Advisor, Strategic Projects, to the VP-RI.
A message from Martha Crago, PhD, C.M., Vice-Principal (Research and Innovation), McGill University
I am pleased to announce that Professor Philippe Gros, PhD, will become Deputy Vice-Principal (Research and Innovation), effective November 1, 2018. The creation of this new role reinforces McGill’s strategic priority to be a world leader in both research and innovation.
The office of Research and Innovation is pleased to announce the appointment of Prof. Martha Crago as Vice-Principal, Research and Innovation (VP-RI), with a term beginning July 1, 2017 and ending June 3, 2022.
By Amanda Testani
Hanadi Sleiman of the Department of Chemistry and Jaswinder Singhof the Department of Plant Science have each received $1.65 million in research grants, to be distributed over six years, from the Natural Sciences and Engineering Research Council of Canada’s (NSERC) Collaborat
Minister of Health Ginette Petitpas Taylor announces investment of $150M to create “Team Canada of Cancer Research”
MONCTON, NB – The federal Minister of Health, Ginette Petitpas Taylor, announced today an investment of $150 million over five years by the Government of Canada for the creation of the Marathon of Hope Cancer Centres network.
In conjunction with a $35 million research funding announcement to support 128 researchers through the Natural Sciences and Engineering Research Council of Canada’s (NSERC) Discovery Grants program, Canada’s Minister of Science and Sport, Kirsty Duncan, was on campus today to sign the
Source: Terry Fox Research Institute
What is the best way to starve cancer cells? What role does obesity play in metastatic breast cancer and how does it affect the tumour microenvironment? Might combining a chemotherapeutic agent with a drug now used to treat diabetes be part of an effective therapy for metastatic breast cancer?